Search results for "Meta-analysis"

showing 10 items of 903 documents

Survival of unresectable hepatocellular carcinoma: A meta-analysis of the control arms of 28 randomized trials

2009

Oncologymedicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicine.diseaselaw.inventionRandomized controlled triallawInternal medicineMeta-analysisHepatocellular carcinomamedicinebusinessDigestive and Liver Disease
researchProduct

Survival and recurrences after curative treatments of HCV-related early hepatocellular carcinoma. A meta-analysis of single arm studies

2017

Oncologymedicine.medical_specialtyHepatologybusiness.industryMeta-analysisInternal medicineGastroenterologymedicineEarly Hepatocellular CarcinomabusinessDigestive and Liver Disease
researchProduct

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis

2015

Abstract: Background: Randomized phase III trials showed interesting, but conflicting results, regarding the treatment of NSCLC, PS2 population. This meta-analysis aims to review all randomized trials comparing platinum-based doublets and single-agents in NSCLC PS2 patients. Materials and methods: Data from all published randomized trials, comparing efficacy and safety of platinum-based doublets to single agents in untreated NSCLC, PS2 patients, were collected. Pooled ORs were calculated for the 1-year Survival-Rate (ly-SR), Overall Response Rate (ORR), and grade 3-4 (G3-4) hematologic toxicities. Results: Six eligible trials (741 patients) were selected. Pooled analysis showed a significan…

Oncologymedicine.medical_specialtyLung NeoplasmsPhase iii trialsSettore MED/06 - Oncologia Medicamedicine.medical_treatmentPopulationSettore MED/21 - Chirurgia ToracicaNSCLClaw.inventionSingle agentOverall response rateRandomized controlled trialPerformance statuNSCLC; Chemotherapy; Performance status; Platinum; Doublet; Single agentlawCarcinoma Non-Small-Cell LungInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansChemotherapyIntensive care medicineeducationRandomized Controlled Trials as TopicPlatinumChemotherapyeducation.field_of_studyPerformance statusbusiness.industryHematologySurvival RateOncologyMeta-analysisDoubletNon small cellHuman medicinePerformance statusbusiness
researchProduct

PMS2: a potential prognostic protein marker in oral squamous cell carcinoma

2020

Background An increase in oral squamous cell carcinoma (OSCC) cases was observed despite the reduction in exposure to classic risk factors. Although the exact cause of this trend remains unknown, epigenetic factors could be contributing to an increased occurrence of these tumors. This study aims to assess the influence of PMS2 protein immunoexpression on the prognosis of patients with OSCC. Material and Methods This study comprised 76 cases of OSCC treated between 2011 and 2016. Immunohistochemical staining for PMS2 was performed. For evaluation, 10 fields per histological section were photographed at a 400x magnification and positively-stained cells were counted with Image J. Mann-Whitney …

Oncologymedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentperiodontal diseaseOral Cancer and Potentially malignant disordersInternal medicineBiomarkers TumormedicinePMS2HumansBasal cellperiodontitisGeneral DentistryUNESCO:CIENCIAS MÉDICASSurvival analysisMismatch Repair Endonuclease PMS2ChemotherapySquamous Cell Carcinoma of Head and NeckProportional hazards modelbusiness.industryResearchMiddle Agedprostate cancerPrognosisImmunohistochemistryProtein markersmeta-analysisstomatognathic diseasesOtorhinolaryngologyHead and Neck NeoplasmsCarcinoma Squamous CellImmunohistochemistryMouth NeoplasmsSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

A Pooled Analysis of Extremely Low-Frequency Magnetic Fields and Childhood Brain Tumors

2010

Pooled analyses may provide etiologic insight about associations between exposure and disease. In contrast to childhood leukemia, no pooled analyses of childhood brain tumors and exposure to extremely low-frequency magnetic fields (ELF-MFs) have been conducted. The authors carried out a pooled analysis based on primary data (1960–2001) from 10 studies of ELF-MF exposure and childhood brain tumors to assess whether the combined results, adjusted for potential confounding, indicated an association. The odds ratios for childhood brain tumors in ELF-MF exposure categories of 0.1–<0.2 μT, 0.2–<0.4 μT, and ≥0.4 μT were 0.95 (95% confidence interval: 0.65, 1.41), 0.70 (95% CI: 0.40, 1.22), and 1.1…

Oncologymedicine.medical_specialtyNeoplasms Radiation-InducedChildhood leukemiaEpidemiologyBrain tumorGlobal HealthCentral nervous system diseaseElectromagnetic FieldsRisk FactorsInternal medicineEpidemiologymedicineHumansChildBrain Neoplasmsbusiness.industryIncidenceConfoundingOdds ratiomedicine.diseaseConfidence intervalSurgeryMeta-analysisbusinessSystematic Reviews and Meta- and Pooled AnalysesAmerican Journal of Epidemiology
researchProduct

1281P The prognostic impact of tissue tumour mutational burden (TMB) in the first-line treatment of advanced non-oncogene addicted non-small cell lun…

2020

Oncologymedicine.medical_specialtyOncogenebusiness.industrynon-small cell lung cancer (NSCLC)Hematologymedicine.diseaselaw.inventionFirst line treatmentOncologyRandomized controlled triallawInternal medicineMeta-analysismedicinebusinessAnnals of Oncology
researchProduct

From palliation to cure: PIPAC for peritoneal malignancies

2019

Introduction Systemic chemotherapy offers poor control over peritoneal disease, maybe as a consequence of restricted drug availability within the abdominal cavity. Locoregional chemotherapy may overcome these shortcomings but its administration is limited to a few patients with confined peritoneal spread. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged in the last years as a novel method of intraperitoneal drug administration. Evidence acquisition We report a meta-analysis of published studies on PIPAC safety and pathological anti-tumoral efficacy on PC from various tumor entities, with the aim of providing more evidence to support further research. This systematic review a…

Oncologymedicine.medical_specialtyPalliative caremedicine.medical_treatmentSettore MED/25 - PSCHIATRIAAntineoplastic AgentsAbdominal cavityDisease03 medical and health sciences0302 clinical medicineInternal medicinemedicinePressureHumansStage (cooking)Adverse effectAerosolsChemotherapybusiness.industryRemission InductionGeneral MedicinePeritoneal carcinomatosisPeritoneal neoplasmsmedicine.anatomical_structure030220 oncology & carcinogenesisMeta-analysisPalliative care030211 gastroenterology & hepatologyDrug therapyPeritoneumbusiness
researchProduct

Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis

2016

Abstract Background Safety of non-operative management for low-risk branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) is debated. Aim To perform a systematic review/meta-analysis to determine their risk of developing pancreatic malignancy and of pancreatic malignancy-related deaths. Methods A MEDLINE search was performed and methodology was based on PRISMA statement. Incidence rates of overall pancreatic malignancy, malignant BD-IPMN, IPMN-distinct PDAC, and of pancreatic malignancy-related death rates were calculated by dividing the total number of events by the total number of person-years (pyrs) of follow-up. Heterogeneity was determined by I2 statistic. Results 20 studies …

Oncologymedicine.medical_specialtyPancreatic malignancyendocrine system diseasesmedicine.medical_treatmentNon-operative managementGastroenterologyMalignant transformation03 medical and health sciencesPancreatectomy0302 clinical medicineRisk FactorsInternal medicinePancreatic cancermedicineHumansWatchful WaitingHepatologybusiness.industryFollow-upMortality ratePancreatic DuctsGastroenterologyPancreatic cancermedicine.diseasePancreatic NeoplasmsCell Transformation Neoplastic030220 oncology & carcinogenesisMeta-analysisPancreatectomyVery low risk030211 gastroenterology & hepatologyfollow-up; non-operative management; pancreatectomy; pancreatic cancerNeoplasms Cystic Mucinous and SerousbusinessWatchful waitingCarcinoma Pancreatic DuctalDigestive and Liver Disease
researchProduct

Hematopoietic and lymphatic cancers in patients with periodontitis : a systematic review and meta-analysis

2019

Background Numerous studies have explored the correlation of periodontal disease (PD) with risk of hematopoietic and lymphatic cancers, but the findings were inconsistent. Therefore, we did a meta-analysis to ascertain the correlation of PD with risk of incident hematopoietic and lymphatic cancers. Material and Methods The authors searched relevant studies in databases (PubMed, Web of Science, and MEDLINE). The summary relative risk (RR) along with 95% confidence interval (CI) was calculated by use of random or fixed effects models. Results Six studies were included in qualitative synthesis. The pooled analysis revealed that PD was significantly associated with an increased risk of hematopo…

Oncologymedicine.medical_specialtyPopulationMEDLINEReview03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineNeoplasmsmedicineHumansPeriodontologyRisk factoreducationPeriodontitisGeneral DentistryPeriodontitiseducation.field_of_studybusiness.industryHematopoietic Stem Cell Transplantation030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Confidence intervalLymphatic systemOtorhinolaryngologyMeta-analysisRelative riskUNESCO::CIENCIAS MÉDICASSurgerybusiness
researchProduct

A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute …

2015

The polymorphism rs16754 of the WT1 gene has been described as a possible prognostic marker in different acute myeloid leukemia (AML) cohorts; however, it is not supported by all the studies. We performed the first meta-analysis evaluating the effect of this polymorphism upon the effectiveness of standard AML therapy. Fourteen cohort studies were included (3618 patients). Patients with the variant allele showed a significant higher overall survival (OS) at 5 years (OR: 1.24, 95% CI: 1.06-1.45, P = 0.007, with dominant model). WT1 did not influence complete remission, but a higher disease-free survival was observed with the variant allele. In the subgroup analysis, Caucasians, pediatric and …

Oncologymedicine.medical_specialtySubgroup analysisPolymorphism Single NucleotideCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsGeneticsmedicineHumansIdarubicinAnthracyclinesWT1 ProteinsGenetic Association StudiesEtoposideSurvival analysisEtoposidePharmacologybusiness.industryCytarabineMyeloid leukemiaSurvival AnalysisLeukemia Myeloid AcuteObservational Studies as Topic030220 oncology & carcinogenesisMeta-analysisImmunologyCytarabineMolecular Medicinebusiness030215 immunologymedicine.drugCohort studyThe Pharmacogenomics Journal
researchProduct